NCT06159556

Effects of Peanuts on Immunity and Cardiometabolic Risk Factors

Effect of Daily Consumption of Peanuts on Immune Function and Cardiometabolic Markers and Risk Factors in Free-living Individuals: A Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Loma Linda University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors.

Detailed description

The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors . To accomplish this objective, a human dietary intervention trial (RCT) with peanuts is proposed. The proposed study is a 12-week parallel-group, free-living, observer-blind, randomized controlled dietary intervention trial. This study will examine the effects of peanuts on markers of immune function, cardiometabolic markers and risk factors and upper respiratory tract infections, in 80 adult male and female volunteers.

Conditions

• Immune Response
• Cardiometabolic Risk Factors

Interventions

Type	Name	Description
OTHER	Peanut intake	Participants will consume 2 ounces of peanuts/peanut butter for 12 weeks

Timeline

• Start date: 2024-01-31
• Primary completion: 2024-09-26
• Completion: 2024-09-26
• First posted: 2023-12-06
• Last updated: 2024-10-02

Locations

1 site across 1 country: United States